glp-1 discovery A timeline of GLP- 1 and clinical development. Created in Mass spectrometry in the development

Lee HM, Napolitano S, Sorokin A, Woods MN, Chowdhury S, Alshenaifi JY, Singh AK, Shen JP, Meric-Bernstam F, Rai K, Kopetz S

GLP-1 medications arent FDA-approved for fertility, but women of reproductive age are already taking these medications, so its important to consider the connections

Cycling protocols typically recommend 4-8 weeks on, followed by 2-4 weeks off , as the standard approach

Safety data indicate no major excess risk with combination therapy, although gastrointestinal effects and class-specific adverse events remain relevant

Comprehensive metabolic phenotyping refines Cardiovascular Risk in Young adults

First, establishing interoperable data infrastructures that connect characterization, digestion, organ-on-chip, in vivo and clinical datasets for nanoencapsulated nutraceuticals would enable robust AI models and digital twins, and avoid repeated underpowered studies on isolated endpoints